AmpC hyperproduction in a Cedecea davisae implant-associated bone infection during treatment: a case report and therapeutic implications
Abstract Background Data on antimicrobial resistance mechanisms are scanty for Cedecea spp., with very variable antibiotic resistance patterns documented. Here we report the first in vivo resistance evolution of a C. davisae clinical isolate in a patient with a complex hand trauma and provide insigh...
Main Authors: | Julia Notter, Salome N. Seiffert, Maria Zimmermann-Kogadeeva, Anja Bösch, Robert Wenger, Carol Strahm, Manuel Frischknecht, David M. Livermore, Baharak Babouee Flury |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-01-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12879-021-07000-y |
Similar Items
-
Cedecea Davisae Bacteraemia after Tocilizumab Usage for Coronavirus Disease-2019 Treatment
by: İrem Akın Şen, et al.
Published: (2021-09-01) -
Characterization of Two Novel AmpC Beta-Lactamases from the Emerging Opportunistic Pathogen, <i>Cedecea neteri</i>
by: Stephen M. Sharkady, et al.
Published: (2023-01-01) -
Identification and Characterization of Aluminium Tolerant Bacteria Isolated from Soil Contaminated by Electroplating and Automobile Waste
by: H. Bisht and N. Kumar
Published: (2023-03-01) -
INFECÇÃO DE PARTES MOLES POR CEDECEA SPP 3
by: Alessandra Shirley Pereira dos Santos, et al.
Published: (2023-10-01) -
Feeding of 0-Group Mugilidae Juveniles in the Coastal and Open Waters of the Black Sea near Sevastopol and the Alien Copepod Oithona davisae as Their Diet Component
by: Irina V. Vdodovich, et al.
Published: (2017-03-01)